Skip to content
10-Q

Quarterly Report

Eastgate Biotech Corp

0001563228-18-000028

← back to feed
Filed
Dec 18, 2018 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2017 · Dec 14, 2018 2.06B sh
Operating Cash Flow Q2 2017 · Jun 30, 2017 −$252.51K
Operating Cash Flow Q2 2017 · Jun 30, 2016 −$574.92K
Current Liabilities Q2 2017 · Jun 30, 2017 $5.82M
Current Liabilities Q2 2017 · Dec 31, 2016 $4.58M
Total Liabilities Q2 2017 · Jun 30, 2017 $5.82M
Total Liabilities Q2 2017 · Dec 31, 2016 $4.62M
Current Assets Q2 2017 · Jun 30, 2017 $946.85K
Total Assets Q2 2017 · Jun 30, 2017 $1.79M
Sga Expense Q2 2017 · Jun 30, 2017 $318.58K
Sga Expense Q2 2017 · Jun 30, 2017 $954.52K
Rd Expense Q2 2017 · Jun 30, 2017 $94.44K
Rd Expense Q2 2017 · Jun 30, 2017 $270.43K
Net Income Q2 2017 · Jun 30, 2017 −$714.82K
Net Income Q2 2017 · Jun 30, 2017 −$1.67M
Gross Profit Q2 2017 · Jun 30, 2017 $57.57K
Gross Profit Q2 2017 · Jun 30, 2017 $57.57K
Revenue Q2 2017 · Jun 30, 2017 $114.5K
Revenue Q2 2017 · Jun 30, 2017 $114.5K